Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: December 01 2020 6:41 pm
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Supplemental Information to the NIH Policy for Data Management and Sharing: Allowable Costs for Data Management and Sharing NOT-OD-21-015 NIH Oct 29 2020 N/A The National Institutes of Health (NIH) recognizes that making data accessible and reusable for other users may incur costs. To assist individuals and entities subject to the final NIH Policy for Data Management and Sharing, this supplemental information outlines categories of allowable NIH costs associated with data management and sharing.
Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional) RFA-ES-20-014 NIEHS Sep 02 2020 Feb 16 2021 The National Institute of Environmental Health Sciences (NIEHS) is announcing the continuation of the Superfund Hazardous Substance Research and Training Program, referred to as Superfund Research Program (SRP) Centers. SRP Center grants will support problem-based, solution-oriented research Centers that consist of multiple, integrated projects representing both the biomedical and environmental science and engineering disciplines; as well as cores tasked with administrative (which includes research translation), data management and analysis, community engagement, research experience and training coordination, and research support functions. The scope of the SRP Centers is taken directly from the Superfund Amendments and Reauthorization Act of 1986, and includes: (1) advanced techniques for the detection, assessment, and evaluation of the effect on human health of hazardous substances; (2) methods to assess the risks to human health presented by hazardous substances; (3) methods and technologies to detect hazardous substances in the environment; and (4) basic biological, chemical, and physical methods to reduce the amount and toxicity of hazardous substances.
Summer Institute for Research Education in Biostatistics and Data Science (R25 Clinical Trial Not Allowed) RFA-HL-22-009 NHLBI Nov 30 2020 Mar 09 2021 The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development.
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) PA-20-275 NIH Oct 06 2020 Jul 24 2023 The National Institutes of Health (NIH) hereby notify recipient organizations holding specific types of NIH grants, listed in the full Funding Opportunity Announcement (FOA), that applications for change of recipient organization status, often referred to in this announcement as Successor-In-Interest, may be submitted to this FOA. Applications for change of recipient organization status are considered prior approval requests (as described in Section 8.1.2.8 of the NIH Grants Policy Statement) and will be routed for consideration directly to the Grants Management Specialist named in the current award. Although successor-in-interest requests may be submitted through this FOA, there is no guarantee that an award will be transferred to the new organization. All applicants are encouraged to discuss potential requests with the awarding IC before submission.
Substance Use/Substance Use Disorder Dissertation Research Award (R36 - Clinical Trials Optional) PA-20-208 NIDA May 08 2020 May 08 2023 The goal of this FOA is to support doctoral candidates from a variety of academic disciplines for up to two years for the completion of the doctoral dissertation research project. Research projects should align with NIDA funding priorities detailed here (https://www.drugabuse.gov/funding/funding-priorities) or within the NIDA Strategic Plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). This award will facilitate the entry of promising new investigators into the field of substance use/substance use disorder (SU(D) research, enhancing the pool of highly talented SU(D) researchers. Applications are particularly encouraged from those who can contribute to diversifying the research workforce as described in the Notice of NIH's Interest in Diversity (NOT-OD-20-031).
Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed) RFA-CA-20-031 NCI Apr 14 2020 Jun 25 2021 The purpose of this funding opportunity announcement (FOA) is to establish an institutional program for mentored training in global cancer research. This program will support research training led by US-based cancer research-intensive institutions working in collaboration with institutions in low and middle-income countries (LMICs). These training programs will be built upon the US institutions pre-existing training infrastructure and research collaborations with LMICs and will leverage these resources to expand the global cancer research workforce both in the US and in LMICs. The overarching goal of this grant program is to build capacity to conduct innovative and collaborative global research projects that will contribute to the advancement of basic, clinical, translational, and population-based cancer research.
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R34 Clinical Trial Optional) RFA-MH-21-150 NIMH Nov 17 2020 Jan 12 2021 The goal of this concept is to encourage new strategies that incorporate multiple levels of influence to reach women in the southern U.S. with targeted HIV prevention strategies. The initiative aims to: (1) elucidate barriers and facilitators to the utilization of HIV prevention strategies among southern U.S.-based women; and (2) develop and test novel interventions to enhance the uptake and adherence to HIV prevention strategies among women living in the southern U.S.
Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional) RFA-MH-21-151 NIMH Nov 17 2020 Jan 12 2021 The goal of this concept is to encourage new strategies that incorporate multiple levels of influence to reach women in the southern U.S. with targeted HIV prevention strategies. The initiative aims to: (1) elucidate barriers and facilitators to the utilization of HIV prevention strategies among southern U.S.-based women; and (2) develop and test novel interventions to enhance the uptake and adherence to HIV prevention strategies among women living in the southern U.S.
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) RFA-HL-20-006 NHLBI Sep 09 2019 Jan 15 2022 The purpose of this program is to provide continued support to Transition Scholars who have successfully matriculated through the NIH Stimulating Access to Research in Residency (StARR) R38 program as resident investigators, and who demonstrate potential and continued interest in pursuing careers as clinician-investigators. Awards will provide 12-24 months of mentored research and career development support to those individuals who completed R38 research training, have secured a clinical fellowship or early-career faculty appointment (as instructor or assistant professor for less than 40 months at the time of submission or resubmission), and propose a strong research and career development plan towards continued, successful research careers.
Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed) PAR-21-038 NIH Nov 09 2020 Dec 29 2023 The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Funding Opportunity Announcement (FOA) may not include preliminary data. The proposed project must be related to the programmatic interests of one or more of the participating NIH Institutes and Centers (ICs) based on their scientific missions. This Funding Opportunity Announcement does not accept applications proposing clinical trials.

Pages

XLS